Egle Therapeutics Competitors and Similar CompaniesClear all
Scorpion Therapeutics's competitors and similar companies include Aeglea, Olema Oncology and ImmunoGen.
 Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ||
Founding Date | Founding Date 2020 | Founding Date 2013 | Founding Date 2007 | Founding Date 1981 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Boston, US HQ Boston, US South San Francisco, US | Locations Austin, US HQ | Locations San Francisco, US HQ San Francisco, US | Locations Waltham, US HQ |
Employees | Employees 1213% decrease | Employees 65117% increase | Employees 9630% increase | Employees 277161% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) 679.2 m | Valuation ($) 8.7 b |
Financial | ||||
Net income | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income ($222.9m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 108m | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company